参考文献/References:
[1] BABELOVA A,MORETH K,TSALASTRA-GREUL W,et al.Biglycan,a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors[J].J Biol Chem,2009,284(36):24035-24048.
[2] BEAMER E,GLNCSR F,HORVTH G,et al.Purinergic mechanisms in neuroinflammation:an update from molecules to behavior[J].Neuropharmacology,2016,104:94-104.
[3] 陈汉泽,田力,薛维爽,等.阿尔茨海默病中炎症反应的研究进展[J].中国临床神经科学,2017,25(3):342-347.
CHEN H Z,TIAN L,XUE W S,et al.Research progress of inflammatory response in Alzheimer′s disease[J].Chin J Clin Neurosci,2017,25(3):342-347.
[4] SOTO F,GARCIA-GUZMAN M,GOMEZ-HERNANDEZ J M,et al.P2X4:an ATP-activated ionotropic receptor cloned from rat brain[J].Proc Natl Acad Sci U S A,1996,93(8):3684-3688.
[5] CHEN H,XIA Q,FENG X,et al.Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice[J].Mol Med Rep,2016,13(1):697-704.
[6] NORENBERG W,ILLES P.Neuronal P2X receptors:localisation and functional properties[J].Naunyn Schmiedebergs Arch Pharmacol,2000,362(4-5):324-339.
[7] BO X,JIANG L H,WILSON H L,et al.Pharmacological and biophysical properties of the human P2X5 receptor[J].Mol Pharmacol,2003,63(6):1407-1416.
[8] 周金凤,覃朝燕,赖炜明,等.嘌呤P2受体的免疫调节功能[J].中国细胞生物学学报,2015,37(8):1151-1157.
ZHOU J F,QIN Z Y,LAI W M,et al.Immunoregulatory effects of purinergic P2 receptors[J].Chin J Cell Biol,2015,37(8):1151-1157.
[9] PRADHAN S,ANDREASSON K.Commentary:progressive inflammation as a contributing factor to early development of Parkinson′s disease[J].Exp Neurol,2013,241:148-155.
[10] LIMA GIACOBBO B,DOORDUIN J,KLEIN H C,et al.Brain-derived neurotrophic factor in brain disorders:focus on neuroinflammation[J].Mol Neurobiol,2019,56(5):3295-3312.
[11] WRIGHT M A,RIBERA A B.Brain-derived neurotrophic factor mediates non-cell-autonomous regulation of sensory neuron position and identity[J].J Neurosci,2010,30 (43):14513-14521.
[12] JIANG X,GANESAN P,RENGARAJAN T,et al.Cellular phenotypes as inflammatory mediators in Parkinson′s disease:interventional targets and role of natural products[J].Biomed Pharmacother,2018,106:1052-1062.
[13] KARPENKO M N,VASILISHINA A A,GROMOVA E A,et al.Interleukin-1β,interleukin-1 receptor antagonist,interleukin-6,interleukin-10,and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson′s disease[J].Cell Immunol,2018,327:77-82.
[14] 李越峰,司昕蕾,牛江涛,等.脑源性神经营养因子及其酪氨酸激酶受体B信号通路在神经性疾病研究进展[J].中国临床药理学杂志,2021,37(9):1121-1125.
LI Y F,SI X L,NIU J T,et al.Research progress of brain-derived neurotrophic factor (BDNF) and BDNF/tyrosine kinase receptor B pathway in neurological diseases[J].Chin J Clin Pharmacol Ther,2021,37(9):1121-1125.
[15] PARAIN K,MURER M G,YAN Q,et al.Reduced expression of brain-derived neurotrophic factor protein in Parkinson′s disease substantia nigra[J].Neuroreport,1999,10(3):557-561.
[16] SILVA T P,POLI A,HARA D B,et al.Time course study of microglial and behavioral alterations induced by 6-hydroxydopamine in rats[J].Neurosci Lett,2016,622:83-87.
[17] GHADERY C,KOSHIMORI Y,COAKELEY S,et al.Microglial activation in Parkinson′s disease using[18F]-FEPPA[J].J Neuroinflammation,2017,14(1):8.
[18] 魏丽萍,薛莉,许文帅,等.P2X4R过表达对帕金森病模型鼠脑黑质中白介素-1β、α突触核蛋白及多巴胺能神经元的影响[J].中国临床神经科学,2019,27(6):617-623.
WEI L P,XUE L,XU W S,et al.The effect of P2X4R overexpression on the number of IL-1β,α-synuclein and dopaminergic neurons in the substantia nigra of PD rat model[J].Chin J Clin Neurosci,2019,27(6):617-623.
[19] 高金照,马江南,王静,等.P2X4信号轴对帕金森病动物模型中铁代谢的影响[J].中华神经科杂志,2020,53(6):423-431.
GAO J Z,MA J N,WANG J,et al.Effect of P2X4 signal axis on iron metabolism in Parkinson′s disease animal model[J].Chin J Neurol,2020,53(6):423-431.
[20] 许文帅,薛莉,蔡敏,等.沉默P2X4R基因对P2X4/NLRP3炎性小体通路介导的BV2小胶质细胞中TNF-α表达的影响[J].中国临床神经科学,2019,27(1):1-8.
XU W S,XUE L,CAI M,et al.Effect of silencing P2X4R gene on TNF-α expression in BV2 microglia mediated by P2X4/NLRP3 inflammatory avenue pathway[J].Chin J Clin Neurosci,2019,27(1):1-8.
[21] 张立群,刘威,王珏.帕金森患者认知功能障碍与血清BDNF及TrkB水平的关系研究[J].中国实用神经疾病杂志,2019,22(21):2321-2326.
ZHANG L Q,LIU W,WANG Y.The association of serum BDNF and TrkB with cognitive impairments in patients with Parkinson′s disease[J].Chin J Pract Nervous Dis,2019,22(21):2321-2326.
[22] ZHOU J,BRADFORD H F,STERN G M,et al.The response of human and rat fetal ventral mesencephalon in culture to the brain derived neurotrophic factor treatment[J].Brain Res,1994,656(1):147-156.
[23] VENKATARAMANA N K,PAL R,RAO S A,et al.Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson′sdisease:a pilot clinical study[J].Stem Cells Int,2012,2012:931902.
[24] HERNANDEZ-CHAN N G,BANNON M J,OROZCO-BARRIOS C E,et al.Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson′s disease[J].J Biomed Sci,2015,22(1):59.
[25] 周岩,崔秀玉,孙晓红,等.大鼠侧脑室注射脂多糖选择性减少黑质脑源性神经营养因子的表达[J].神经解剖学杂志,2021,37(5):545-549.
ZHOU Y,CUI X Y,SUN X H,et al.Selective reduction of the expression of brain-derived neurotrophic factor in substantia nigra following introcerebroventricular injection of lipopolysaccharide in rat[J].Chin J Neuroanat,2021,37(5):545-549.
[26] PARAIN K,MURER M G,YAN Q,et al.Reduced expression of brain-derived neurotrophic factor protein in Parkinson′s disease substantia nigra[J].Neuroreport,1999,10(3):557-561.
[27] 彭雪梅,邓靓,李琴,等.帕金森病患者血尿酸水平与认知功能、炎性因子及神经细胞因子的相关性[J].疑难病杂志,2019,18(2):119-122.
PENG X M,DENG L,LI Q,et al.The correlation between serum uric acid level and cognitive function,inflammatory factors and neurocytokines in patients with Parkinson′s disease[J].Chin J Diffic Compl Cas,2019,18(2):119-122.
相似文献/References:
[1]马琪林,鲁丛霞,蔡琰,等.帕金森病患者血小板线粒体谷氨酸载体和复合物活性研究 [J].新乡医学院学报,2007,24(02):114.
[2]洪丽,李珂,闫晓海,等.瞬目反射与肛门括约肌肌电图对帕金森病患者病情分期判定的意义[J].新乡医学院学报,2012,29(12):936.
[3]朱丰霞,常海敏,段 瑛,等.人参皂苷 Rg1对帕金森病小鼠黑质中酪氨酸羟化酶及ephrinB2和磷酸化 c-Jun表达的影响[J].新乡医学院学报,2014,31(10):781.[doi:10.7683/xxyxyxb.2014.10.003]
[4]魏家彬,杨 帆,王淑秀.人参皂苷Rg1对1甲基4苯基1,2,3,6四氢吡啶诱导的帕金森病小鼠黑质酪氨酸蛋白激酶A4表达的影响[J].新乡医学院学报,2015,32(05):404.
[5]李 乐,黄志勇,贺文麟.血浆同型半胱氨酸、催乳素水平与帕金森病及帕金森病痴呆相关性分析[J].新乡医学院学报,2015,32(05):438.
[6]宋金辉,王普清,丁旭东,等.节律性视觉刺激对帕金森病患者运动功能及平衡能力的影响[J].新乡医学院学报,2014,31(12):1006.[doi:10.7683/xxyxyxb.2014.12.011]
[7]孙 冰,徐玉英.氧化苦参碱对帕金森小鼠中枢神经系统氧化应激的影响[J].新乡医学院学报,2020,37(6):509.[doi:10.7683/xxyxyxb.2020.06.002]
SUN Bing,XU Yuying.Effects of oxymatrine on oxidative stress of central nervous system in Parkinson mice[J].Journal of Xinxiang Medical University,2020,37(3):509.[doi:10.7683/xxyxyxb.2020.06.002]
[8]张静怡,邓永宁,张 萌,等.Sirt3基因过表达慢病毒载体的构建及其在人神经母细胞瘤SH-SY5Y细胞中的表达[J].新乡医学院学报,2021,38(1):006.[doi:10.7683/xxyxyxb.2021.01.002]
ZHANG Jingyi,DENG Yongning,ZHANG Meng,et al.Construction of lentiviral vector with Sirt3 gene overexpression and its expression in human neuroblastoma SH-SY5Y cells[J].Journal of Xinxiang Medical University,2021,38(3):006.[doi:10.7683/xxyxyxb.2021.01.002]
[9]汤丹丹,张 勋,符益纲,等.磁共振波谱在原发性帕金森病治疗效果评估中的应用价值[J].新乡医学院学报,2021,38(8):734.[doi:10.7683/xxyxyxb.2021.08.007]
TANG Dandan,ZHANG Xun,FU Yigang,et al.Value of magnetic resonance spectroscopy in evaluating the therapeutic effect of primary Parkinson′s disease[J].Journal of Xinxiang Medical University,2021,38(3):734.[doi:10.7683/xxyxyxb.2021.08.007]
[10]赵雪薇,陈珮琪,牛延翔,等.帕金森病的病因及发病机制研究进展[J].新乡医学院学报,2021,38(4):378.[doi:10.7683/xxyxyxb.2021.04.018]